The Latest Cardiac and Vascular News
TORONTO, March 5, 2020 /CNW/ – Baylis Medical is honoured to be recognized as one of Canada’s Best Managed Companies for the third consecutive year. The prestigious award program, which is run by Deloitte, recognizes Canadian companies that invest in technology and sustainable practices, have strategic […]
TORONTO, June 19, 2019 /PRNewswire/ – A cost-effectiveness analysis completed by the University of California, San Francisco (UCSF) and Baylis Medical has shown that use of Baylis’ RF transseptal needle results in cost savings per procedure, compared to use of a mechanical transseptal needle. The […]
TORONTO, March 8, 2018 /PRNewswire/ – Baylis Medical Company is proud to announce that it has been named a 2018 winner of Canada’s Best Managed Companies, one of the country’s leading business award programs honouring excellence in Canadian-owned and managed businesses. Established […]
TORONTO, Jan. 22, 2018 /PRNewswire/ – Baylis Medical, a global medical device company, has taken the next pivotal step in its global expansion strategy with the official opening of a new state-of-the-art laboratory in Mississauga, Ontario. The new extrusion lab will allow […]
TORONTO, Nov. 21, 2017 /PRNewswire/ – Baylis Medical Company Inc. has launched a hands-on workshop in Europe that will train cardiologists on innovative tools that enable access to the heart from any approach. This includes a growing number of procedures that require physicians to […]
WASHINGTON, Oct. 25, 2017 /PRNewswire/ – Baylis Medical Company, a leading developer, manufacturer, and supplier of state-of-the-art interventional cardiology products, has announced that President and co-Founder Kris Shah has been named to the Advanced Medical Technology Association’s (AdvaMed) Accel Board of Directors. “I am honoured to be […]
TORONTO, Oct. 17, 2017 /PRNewswire/ – Baylis Medical Company Inc. and Siemens Healthineers are co-sponsoring a first-of-its kind training program aimed at helping cardiologists perform a complex procedure that is quickly becoming the gold standard for treating patients with atrial fibrillation and […]
